|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 1.10|
* CGC could trade up to over $30 on the successful House vote passage of the SAFE Banking Act announced last evening * While the short term may remain rocky (pot stocks are down by nearly 50% since April), investors with longer term timeframes shoul...
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
Illogical action likely driven by an exchange-traded fund on this cannabis company shows how both the Efficient Market Hypothesis and irrationality can co-exist.
There is no technical reason to go long on beleaguered CTST, and it has not created a bottom, yet.
The cannabis company's $4 billion market cap continues to dominate the sector without enough reason.
So many stocks, so much news, so little time. The good news is I'm letting you borrow my shovel.
Blaming the costs of coming public as your reasoning for a sharp drop in net income isn't a great look.
I believe the best move here is to cut the position in half and take a loss.
Five top marijuana stocks and four CBD plays in this speculative space.
I know I haven't talked much about the overall markets today. My analysis falls well short of Dougie in this regard. I tend to trade or focus on specific sectors with volatility and action. That means I spend a lot of time with cannabis, eSports, Ch...
Recently uplisted CTST is a huge player in the medical marijuana market.